What Will 2023 Bring for Alexandria Real Estate Equities?
2022 was a challenging year for healthcare-focused office real estate investment trust (REIT) Alexandria Real Estate Equities (NYSE: ARE). Despite it being a record-breaking year for the life sciences and biotech industries, the stock is down 20% this year. Low investor sentiment for the office industry, coupled with a bear market and rising interest rates, have weighed on the company despite its maintaining healthy earnings.
Could 2023 be the year it comes back? Let's take a closer look at where this premier office REIT could be headed in the coming year.
The global pandemic ushered in record-breaking years of growth for the life sciences industry. The race to deliver pandemic-related new medicines and medical technologies led to increased demand for high-quality office space -- precisely what Alexandria Real Estate Equities owns and leases.
Source Fool.com
